CCN2 and hepatocellular carcinoma: Hou et al. [38] showed that CCN2 is related to the formation of bone metastases in HCC, whereas other studies have indicated that CCN2 could serve as a potential prognostic biomarker [39] and that the inhibition of CCN2 blocks the progression of HCC [40].